.
ORL financial statements
* Numbers in millions
| Capitalization * | 2 740 |
|---|---|
| EV * | 2 609 |
| Number of shares * | 331 |
| EPS | -0,27 |
| Revenue * | 85 |
| Net income * | -89 |
| Operating profit * | 5 |
| Total liabilities * | 624 |
| Net debt * | 78 |
| Total assets * | 1 349 |
| Equity * | 667 |
| Cash and investments * | 258 |
.
ORL valuation
| P/E | -30,62 |
|---|---|
| P/B | 4,11 |
| P/S | 32,32 |
| E/P | -3 |
| P/FCF | -24,18 |
.
ORL profitability
| ROE | -13% |
|---|---|
| ROA% | -7% |
| ROIC% | 0% |